A growing number of studies in nephrology are focusing on biomarkers for chronic kidney disease (CKD). Here, Michael Shlipak and Erica Day describe biomarkers that are used to predict risk of developing CKD and outline the statistical methods that can be used to assess the performance of candidate biomarkers. The authors also provide a conceptual framework for interpreting the results of studies evaluating biomarkers of declining kidney function and incident CKD.
- Michael G. Shlipak
- Erica C. Day